These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8582162)

  • 41. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.
    Spinelli C; Di Giacomo M; Costanzo S; Elisei R; Miccoli P
    J Pediatr Surg; 2010 Aug; 45(8):1610-6. PubMed ID: 20713208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early onset of medullary thyroid carcinoma in a kindred with multiple endocrine neoplasia type iia associated with cutaneous lichen amyloidosis.
    Lemos MC; Carrilho F; Rodrigues FJ; Santos P; Carvalheiro M; Ruas MA; Regateiro FJ
    Endocr Pract; 2002; 8(1):19-22. PubMed ID: 11939755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
    Wells SA; Chi DD; Toshima K; Dehner LP; Coffin CM; Dowton SB; Ivanovich JL; DeBenedetti MK; Dilley WG; Moley JF
    Ann Surg; 1994 Sep; 220(3):237-47; discussion 247-50. PubMed ID: 7916559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?
    Frohnauer MK; Decker RA
    Surgery; 2000 Dec; 128(6):1052-7;discussion 1057-8. PubMed ID: 11114642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.
    Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Haas OA; Vierhapper H; Niederle B
    Am J Surg Pathol; 2001 Oct; 25(10):1245-51. PubMed ID: 11688458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hereditary thyroid cancer can be cured by prophylactic surgery].
    Wallin G; Bondesson AG; Farnebo LO; Hallengren B; Hamberger B; Jansson S; Nilsson O; Nordenskjöld M; Smeds S; Svensson KA; Wihlborg O; Zedenius J
    Lakartidningen; 2001 Jun; 98(25):3024-8. PubMed ID: 11462876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.
    McMahon R; Mulligan LM; Healey CS; Payne SJ; Ponder M; Ferguson-Smith MA; Barton DE; Ponder BA
    Hum Mol Genet; 1994 Apr; 3(4):643-6. PubMed ID: 7915166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience.
    Miccoli P; Elisei R; Donatini G; Materazzi G; Berti P
    Surg Endosc; 2007 Jan; 21(1):120-3. PubMed ID: 16960675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers].
    Belli S; Storani ME; Dourisboure RJ; Podestá EJ; Solano AR
    Medicina (B Aires); 2003; 63(1):41-5. PubMed ID: 12673960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children.
    van Heurn LW; Schaap C; Sie G; Haagen AA; Gerver WJ; Freling G; van Amstel HK; Heineman E
    J Pediatr Surg; 1999 Apr; 34(4):568-71. PubMed ID: 10235324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.
    Aydoğan Bİ; Yüksel B; Tuna MM; Navdar Başaran M; Akkurt Kocaeli A; Ertörer ME; Aydın K; Güldiken S; Şimşek Y; Cihan Karaca Z; Yılmaz M; Aktürk M; Anaforoğlu İ; Kebapçı N; Duran C; Taşlıpınar A; Kulaksızoğlu M; Gürsoy A; Dağdelen S; Erdoğan MF
    J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):13-20. PubMed ID: 26758973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia.
    Diaz-Cano SJ; de Miguel M; Blanes A; Tashjian R; Wolfe HJ
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3948-57. PubMed ID: 11502837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
    Schellhaas E; König C; Frank-Raue K; Buhr HJ; Hotz HG
    Surgery; 2009 Nov; 146(5):906-12. PubMed ID: 19744457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
    Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
    Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].
    Frank-Raue K; Heimbach C; Rondot S; Usadel KH; Meng W; Varma C; Fuchs-Hammoser R; Höppner W; Schulze E; Raue F
    Dtsch Med Wochenschr; 2003 Sep; 128(39):1998-2002. PubMed ID: 14508694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indication and timing of thyroid surgery for patients with hereditary medullary thyroid cancer syndromes.
    Ogilvie JB; Kebebew E
    J Natl Compr Canc Netw; 2006 Feb; 4(2):139-47. PubMed ID: 16451770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.